Table 1 Number of responders and nonresponders to insulin glargine 100 Units/mL at 24 weeks by composite HbA1c endpoint
HbA1c < 7% (Yes/No) | ≥1% reduction in HbA1c (Yes/No) | Responders (HbA1c < 7% or ≥ 1% reduction) n (%) | Nonresponders (HbA1c ≥ 7% and < 1% reduction) n (%) |
|---|---|---|---|
Yes | Yes | 595 (50) | – |
Yes | No | 88 (7) | – |
No | Yes | 505 (43) | – |
No | No | 297 (20) | |
Total (N = 1485) | 1188 (80) | 297 (20) | |